# Efficacy and Safety of THR-4109 in Obese Subjects

> **NCT00485017** · PHASE2 · COMPLETED · sponsor: **Theracos** · enrollment: 220 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** THR-4109
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00485017
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2019-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00485017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00485017, "Efficacy and Safety of THR-4109 in Obese Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00485017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*